🔥🐔 BizChicken 🐔🔥
Companies Similar to Cingulate Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Athira Pharma, Inc.
ATH-1017
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.
Symbol: ATHA
Recent Price: $0.55
Industry: Biotechnology
CEO: Dr. Mark J. Litton M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 18706 North Creek Parkway, Bothell, WA 98011
Phone: 425 620 8501
Last updated: 2024-12-31
Cyclerion Therapeutics, Inc.
CY6463
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious CNS diseases, with products like CY6463 for mitochondrial encephalomyopathy and Alzheimer's disease.
Symbol: CYCN
Recent Price: $3.45
Industry: Biotechnology
CEO: Dr. Regina Graul Ph.D.
Sector: Healthcare
Employees: 1
Address: 245 First Street, Cambridge, MA 02142
Phone: 857 327 8778
Last updated: 2024-12-31
PharmaCyte Biotech, Inc.
Cell-in-a-Box
Pharma Cyte Biotech, Inc. is a biotechnology company focused on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites. Their therapies are based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology, used for treating various cancers and diabetes.
About | Management | Directors | ESG | About | Directors | Contact | ESG | About | About | About | About
Symbol: PMCB
Recent Price: $1.55
Industry: Biotechnology
CEO: Mr. Joshua N. Silverman
Sector: Healthcare
Employees: 2
Address: 3960 Howard Hughes Parkway, Las Vegas, NV 89169
Phone: 917 595 2850
Leadership
- Joshua N. Silverman, Independent Director
- Dr. Michael M. Abecassis, Independent Director
- Robert Weinstein, Director
- Wayne R. Walker, Director
- Jonathan L. Schechter, Independent Director
- Dr. Abecassis, Director
- Kenneth L. Waggoner, Independent Director
- Daniel C. Farb, Independent Director
- Daniel C. Allen, Independent Director
- Jack E. Stover, Independent Director
Last updated: 2024-12-31
Syndax Pharmaceuticals, Inc.
SNDX-5613, SNDX-6352 (axatilimab), Entinostat
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for cancer treatment, including innovative candidates like SNDX-5613 and SNDX-6352. It collaborates with notable institutions like the National Cancer Institute and has a license agreement with Kyowa Hakko Kirin Co., Ltd.
Symbol: SNDX
Recent Price: $12.52
Industry: Biotechnology
CEO: Mr. Michael A. Metzger M.B.A.
Sector: Healthcare
Employees: 184
Address: 35 Gatehouse Drive, Waltham, MA 02451
Phone: 781 419 1400
Last updated: 2024-12-31
Tonix Pharmaceuticals Holding Corp.
TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.
Symbol: TNXP
Recent Price: $0.36
Industry: Biotechnology
CEO: Dr. Seth Lederman M.D.
Sector: Healthcare
Employees: 103
Address: 26 Main Street, Chatham, NJ 07928
Phone: 862 799 8599
Last updated: 2024-12-31
Alto Neuroscience, Inc.
ALTO-100, ALTO-300, ALTO-101, ALTO-203, ALTO-202
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company specializing in psychiatry drug development, with a range of innovative treatments targeting major depressive disorder and cognitive impairments.
Symbol: ANRO
Recent Price: $4.20
Industry: Biotechnology
CEO: Dr. Amit Etkin M.D., Ph.D.
Sector: Healthcare
Employees: 78
Address: 369 South San Antonio Road, Los Altos, CA 94022
Phone: (650) 200-0412
Last updated: 2024-12-31
Taysha Gene Therapies, Inc.
TSHA-120, TSHA-102, TSHA-121, TSHA-118, TSHA-105, TSHA-101
Taysha Gene Therapies, Inc. focuses on developing adeno-associated virus-based gene therapies for treating monogenic diseases of the central nervous system, with a pipeline including treatments for conditions such as giant axonal neuropathy, Rett syndrome, and GM2 gangliosidosis.
Symbol: TSHA
Recent Price: $1.73
Industry: Biotechnology
CEO: Mr. Sean P. Nolan
Sector: Healthcare
Employees: 52
Address: 3000 Pegasus Park Drive, Dallas, TX 75247
Phone: 214 612 0000
Last updated: 2024-12-31
VistaGen Therapeutics, Inc.
PH94B
Vista Gen Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing medicines for anxiety, depression, and other CNS disorders. Their CNS pipeline includes PH94B and PH10, rapid-onset neuroactive nasal sprays for anxiety and depression, respectively.
About | Directors | About | Contact | Contact | Careers | Careers | About | About | About | Careers
Symbol: VTGN
Recent Price: $2.81
Industry: Biotechnology
CEO: Mr. Shawn K. Singh J.D.
Sector: Healthcare
Employees: 41
Address: 343 Allerton Avenue, South San Francisco, CA 94080
Phone: 650 577 3600
Leadership
- Ann Cunningham, MBA, Director
- Joanne Curley, Ph.D., Director
- Maggie FitzPatrick, Chair of the Board
- Jerry Gin, Ph.D., MBA, Director
- Mary L. Rotunno, J.D., Director
- Jon S. Saxe, J.D., LL.M, Director
- Shawn K. Singh, J.D., Chief Executive Officer and Director
Last updated: 2024-12-31
Adial Pharmaceuticals, Inc.
AD04
Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for addiction and related disorders. Its lead product, AD04, is in Phase III clinical trial for alcohol use disorder treatment.
Symbol: ADIL
Recent Price: $1.03
Industry: Biotechnology
CEO: Mr. Cary John Claiborne MBA
Sector: Healthcare
Employees: 4
Address: 1180 Seminole Trail, Charlottesville, VA 22901
Phone: 434 422 9800
Last updated: 2024-12-31
Alzamend Neuro, Inc.
AL001 and AL002
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing products for neurodegenerative and psychiatric disorders. Their pipeline includes AL001 for Alzheimer's and psychiatric disorders, and AL002 for Alzheimer's disease using a novel vaccine approach.
About | About | Contact | Contact | Contact | Contact | Careers | About | About | About | About | About
Symbol: ALZN
Recent Price: $1.20
Industry: Biotechnology
CEO: Mr. Stephan Jackman
Sector: Healthcare
Employees: 4
Address: 3500 Lenox Road NE, Atlanta, GA 30326
Phone: 844 722 6333
Last updated: 2024-12-31
Axsome Therapeutics, Inc.
AXS-05, AXS-07, AXS-12, AXS-14
Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system disorders such as major depressive disorder, migraine, narcolepsy, and fibromyalgia.
About | Leadership | Directors | About | About | About | About | About | About | Contact | Careers | Careers | About | About
Symbol: AXSM
Recent Price: $84.78
Industry: Biotechnology
CEO: Dr. Herriot Tabuteau M.D.
Sector: Healthcare
Employees: 589
Address: 22 Cortlandt Street, New York, NY 10007
Phone: 212 332 3241
Leadership
- Herriot Tabuteau, MD, CHIEF EXECUTIVE OFFICER
- Nick Pizzie, CPA, MBA, CHIEF FINANCIAL OFFICER
- Mark Jacobson, MA, CHIEF OPERATING OFFICER
- Hunter Murdock, Esq., GENERAL COUNSEL
- ari Maizel, Executive Vice President, Head of Commercial
- Mark Coleman, MD, DIRECTOR
- Roger Jeffs, PhD, DIRECTOR
- Susan Mahony, PhD, MBA, DIRECTOR
- Mark Saad, DIRECTOR
Last updated: 2024-12-31
Cognition Therapeutics, Inc.
CT1812
Cognition Therapeutics is a clinical-stage biopharmaceutical company specializing in small molecule therapeutics for age-related degenerative diseases and central nervous system disorders. Its lead product, CT1812, is designed to treat Alzheimer's disease and dementia with Lewy bodies.
Symbol: CGTX
Recent Price: $0.75
Industry: Biotechnology
CEO: Ms. Lisa Ricciardi
Sector: Healthcare
Employees: 25
Address: 2500 Westchester Avenue, Purchase, NY 10577
Phone: 412 481 2210
Leadership
- Lisa Ricciardi, Chief Executive Officer
- Anthony C. Caggiano, M.D., Ph.D., Chief Medical Officer, Head of R&D
- John Doyle, Chief Financial Officer
- Anita Cornet, Head of Quality
- Theresa Devins, DrPH, Vice President, Clinical Operations
- Mary Hamby, Ph.D., Vice President, Research
- Bobby Horn, Corporate Controller
- Jennifer Iaci, Vice President, Development Operations
- Steven A. Weissman, Ph.D., Vice President and Head of CMC
- Jack A. Khattar, CEO
- Aaron Fletcher, Ph.D.,
- Brett P. Monia, Ph.D., CEO
- Ellen B. Richstone,
- Peggy Wallace,
Last updated: 2024-12-31
Cingulate Inc.
CTx-1301
Cingulate Inc. is focused on developing product candidates for treating attention-deficit/hyperactivity disorder (ADHD) and anxiety disorders. Its pipeline includes CTx-1301 and CTx-1302 for ADHD, and CTx-2103 for anxiety.
About | Management | Directors | About | About | Contact | Contact | Careers | About | About | About
Symbol: CING
Recent Price: $4.98
Industry: Biotechnology
CEO: Dr. Shane J. Schaffer Pharm.D.
Sector: Healthcare
Employees: 13
Address: 1901 West 47th Place, Kansas City, KS 66205
Phone: 913 942 2300
Leadership
- Shane J. Schaffer, PharmD, Chairman, Chief Executive Officer
- Peter J. Werth, Director
- Jeff Ervin, Director
- Bryan Lawrence, Director
- Jay Roberts, Director
Last updated: 2024-12-31
Compass Therapeutics, Inc.
CTX-009, CTX-471, CTX-8371
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing antibody-based therapeutics to treat various human diseases. Their clinical stage products include investigational bispecific antibodies like CTX-009 and monoclonal antibodies such as CTX-471.
Symbol: CMPX
Recent Price: $1.48
Industry: Biotechnology
CEO: Dr. Thomas J. Schuetz M.D., Ph.D.
Sector: Healthcare
Employees: 32
Address: 80 Guest Street, Boston, MA 02135
Phone: 617 500 8099
Last updated: 2024-12-31
Intra-Cellular Therapies, Inc.
CAPLYTA
Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on developing novel drugs for the treatment of neuropsychiatric and neurologic diseases targeting intracellular signaling in the central nervous system. Key products include CAPLYTA for schizophrenia and ongoing developments in treatments for bipolar depression, autism spectrum disorder, and more.
About | About | Leadership | Directors | Sustainability | Contact | Careers | Careers | About | News | About | Careers
Symbol: ITCI
Recent Price: $83.48
Industry: Drug Manufacturers - Specialty & Generic
CEO: Dr. Sharon Mates Ph.D.
Sector: Healthcare
Employees: 610
Address: 430 East 29th Street, New York, NY 10016
Phone: 646 440 9333
Leadership
- Sharon Mates, Ph.D., Chairman, Founder & Chief Executive Officer
- Michael I. Halstead, J.D., President
- Mark Neumann, Executive Vice President, Chief Commercial Officer
- Suresh Durgam, M.D., Executive Vice President, Chief Medical Officer
- Sanjeev Narula, Executive Vice President, Chief Financial Officer
- John A. Bardi, Senior Vice President, Market Access, Policy and Government Affairs
- Robert E. Davis, Ph.D., Senior Vice President, Chief Scientific Officer
- Karen Sheehy, Esq., Senior Vice President and Chief Compliance Officer
- Michael Olchaskey, Pharm.D., Senior Vice President, Head of Regulatory Affairs
- Juan Sanchez, M.D., Vice President of Corporate Communications and Investor Relations
- Willie R. Earley, M.D., Senior Vice President, Head of Clinical Development
- Joel S. Marcus, J.D., CPA, Executive Chairman & Founder
- Rory B. Riggs, MBA, Co-Founder and Director
- E. Rene Salas, CPA, Former Senior Client Partner at Ernst & Young, LLP; Former CFO, Wellstat, LLC
- Robert L. Van Nostrand, Chairman, Metabolix; Board Member, Achillion Pharmaceuticals; Former CFO, OSI Pharmaceuticals
Last updated: 2024-12-31
Protagenic Therapeutics, Inc.
PT00114
Protagenic Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing therapeutics for stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, aims to regulate stress response and restore healthy brain function.
Symbol: PTIX
Recent Price: $0.54
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 1
Address: 149 Fifth Avenue, New York, NY 10010
Phone: 212 994 8200
Last updated: 2024-12-31
Soligenix, Inc.
SGX301 (Hy Bryte), SGX942, SGX203, SGX302
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases, operating in the Specialized Bio Therapeutics and Public Health Solutions segments.
About | Directors | About | About | About | About | About | About | Contact | About | About | About | About | About | Careers | Careers | About | About | About | About | About | About | About
Symbol: SNGX
Recent Price: $2.91
Industry: Biotechnology
CEO: Dr. Christopher J. Schaber Ph.D.
Sector: Healthcare
Employees: 13
Address: 29 Emmons Drive, Princeton, NJ 08540
Phone: 609 538 8200
Leadership
- Christopher J. Schaber, PhD, Chairman, President and Chief Executive Officer
- Gregg A. Lapointe, CPA, MBA, Board Director
- Diane L. Parks, MBA, Board Director
- Robert J. Rubin, MD, Board Director
- Jerome Zeldis, MD, PhD, Board Director
Last updated: 2024-12-31
Shattuck Labs, Inc.
SL-172154
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States, with its lead product candidate being SL-172154.
About | About | News | About | Contact | Culture | Leadership | Leadership
Symbol: STTK
Recent Price: $1.17
Industry: Biotechnology
CEO: Dr. Taylor H. Schreiber M.D., Ph.D.
Sector: Healthcare
Employees: 75
Address: 500 West 5th Street, Austin, TX 78703
Phone: 512 900 4690
Last updated: 2024-12-31
Vaxxinity, Inc.
UB-311, UB-312, UB-313, UB-612
Vaxxinity, Inc. is a biotechnology company focused on developing product candidates for neurology and coronavirus-related treatments, including Alzheimer's, Parkinson's disease, migraines, and SARS-CoV-2.
Symbol: VAXX
Recent Price: $0.00
Industry: Biotechnology
CEO: Ms. Mei Mei Hu J.D.
Sector: Healthcare
Employees: 57
Address: 1717 Main Street, Dallas, TX 75201
Phone: 254 244 5739
Last updated: 2024-11-08
Praxis Precision Medicines, Inc.
PRAX-114, PRAX-944, PRAX-562, PRAX-222, KCNT1 program
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders characterized by neuronal imbalance, with multiple products in different stages of clinical trials.
Symbol: PRAX
Recent Price: $76.26
Industry: Biotechnology
CEO: Mr. Marcio Silva De'Souza M.B.A.
Sector: Healthcare
Employees: 82
Address: 99 High Street, Boston, MA 02110
Phone: 617 300 8460
Last updated: 2024-12-31